Xenon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.About XENE
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
CEOIan C. Mortimer
CEOIan C. Mortimer
Employees259
Employees259
HeadquartersBurnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded1996
Founded1996
Employees259
Employees259
XENE Key Statistics
Market cap3.05B
Market cap3.05B
Price-Earnings ratio-15.25
Price-Earnings ratio-15.25
Dividend yield—
Dividend yield—
Average volume325.69K
Average volume325.69K
High today$41.72
High today$41.72
Low today$39.59
Low today$39.59
Open price$41.72
Open price$41.72
Volume176.07K
Volume176.07K
52 Week high$50.99
52 Week high$50.99
52 Week low$27.99
52 Week low$27.99
XENE News
TipRanks 2d
Xenon Pharmaceuticals Spotlights XEN1101 Progress - TipRanks.com - TipRanksXenon Pharmaceuticals (XENE) has released an update. Xenon Pharmaceuticals highlighted their clinical data for XEN1101, a promising treatment for epilepsy and...
Simply Wall St 2d
Calculating The Fair Value Of Xenon Pharmaceuticals Inc.Key Insights Using the 2 Stage Free Cash Flow to Equity, Xenon Pharmaceuticals fair value estimate is US$37.93 Current share price of US$41.31 suggests Xenon...
Analyst ratings
100%
of 17 ratingsBuy
100%
Hold
0%
Sell
0%